Australian health card is "back door" ID card

7 May 2006

The Australian government is planning the introduction of a controversial "smart card" to crack-down on Medicare and other welfare-related fraud, in a move that is considered by critics to be a back-door national identity card program.

Tony Abbott, Australia's Health Minister told Australia's Broadcasting Corporation radio news that the card would only hold details of allergies, blood type and basic identifying information. He said: "that could be the difference between life and death. So this is not something that should scare people. It's about delivering better services, it's about ensuring that people can't steal your identity, it's about trying to ensure that we get better value for taxpayers' dollars."

The scale of Medicare fraud in Australia is not known, but the cost of introducing the card is estimated at A$1.0 billion ($743.4 million) and the government believes that it would cover its costs in terms of reduced benefit fraud within five years. The federal government, despite assurances about privacy and civil rights, is reported to be split on the issue of the benefit cards.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight